Evaluation of Transthoracic Echocardiography Parameters and Their Changes in Blood Donor Volunteers
EDoS
1 other identifier
interventional
66
1 country
1
Brief Summary
This study investigates the impact of blood donation on transthoracic echocardiography (TTE) parameters in healthy volunteers, aiming to enhance the understanding of hemodynamic changes associated with mild blood loss and assess non-invasive monitoring techniques for early hemorrhage detection. Conducted as a prospective, interventional study with minimal risk, this research is designed to simulate a controlled hemorrhage in a civilian setting, using voluntary blood donation as a model to study the physiological effects of blood loss of approximately 6 mL/kg. Rationale and Background Hemorrhagic shock is a leading cause of preventable death in trauma patients, particularly among younger populations. The ability to rapidly detect and quantify blood loss is crucial in trauma management, as delayed or excessive resuscitation can lead to adverse outcomes, including multi-organ failure and coagulopathy. Traditional methods of monitoring blood volume and cardiac output, such as invasive catheterization or imaging techniques like CT scans, may not be feasible or practical in prehospital settings. TTE, particularly the measurement of the aortic time-velocity integral (TVI) using Doppler echocardiography, presents a non-invasive and potentially valuable tool for assessing cardiac output and detecting early hemodynamic changes due to blood loss. Primary Objective The primary objective of this study is to evaluate whether the aortic TVI decreases by at least 10% following a controlled blood volume reduction during blood donation. This decrease in TVI could serve as a reliable marker of reduced cardiac output and might allow clinicians to detect mild to moderate blood loss in trauma patients non-invasively. Secondary Objectives The study also aims to examine additional echocardiographic parameters that may indicate changes in hemodynamic status following blood loss. Secondary objectives include measuring changes in: Shock index (SI), calculated as the ratio of heart rate to systolic blood pressure, a parameter often associated with hypovolemia. E-wave and e'-wave velocities, which reflect left ventricular filling pressures and diastolic function. Ratios of E/e' and E/A, which are indicative of left ventricular diastolic function and filling pressures. Global longitudinal strain of the left ventricle (GLS), which represents myocardial contractility. Methods Healthy adult volunteers meeting eligibility criteria for blood donation are recruited from local blood donation centers. Participants undergo baseline TTE to measure the aortic TVI, E-wave, e'-wave, and other relevant parameters before donation. Following a blood donation procedure of approximately 450 mL (representing a 6 mL/kg blood loss for the average volunteer), TTE is repeated immediately after donation and then 15 minutes post-donation to capture any transient changes in cardiac output and ventricular function. Volunteers receive structured hydration and are observed for any adverse events. Outcome Measures The primary outcome measure is a decrease of at least 10% in aortic TVI from baseline immediately following blood donation, which would confirm the sensitivity of TTE to detect mild hypovolemia. Secondary outcome measures include changes in the shock index, variations in Doppler-derived E and e' waves, and the E/e' and E/A ratios, assessed immediately and 15 minutes post-donation. The study will also monitor the global longitudinal strain (GLS) as an additional measure of left ventricular performance. Statistical Analysis The required sample size was calculated to detect a 10% decrease in TVI with 90% power at a 5% significance level, resulting in a target enrollment of 66 participants. Descriptive statistics will be used for continuous variables, expressed as mean ± standard deviation or median and interquartile range as appropriate. Paired t-tests or Wilcoxon signed-rank tests will assess changes in parameters before and after blood donation. Each participant's response will be classified as positive if a decrease of at least 10% in TVI is observed, or negative if the decrease is below this threshold. Potential Impact If successful, this study could validate the use of TTE-derived parameters, such as aortic TVI and shock index, as non-invasive markers for early detection of blood loss in trauma patients. By providing real-time insight into hemodynamic changes, this approach could improve decision-making in prehospital and emergency settings, allowing clinicians to tailor resuscitation strategies based on the actual volume of blood loss. This could reduce the risks associated with both under-resuscitation and over-resuscitation, ultimately improving patient outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 10, 2025
CompletedStudy Start
First participant enrolled
October 2, 2025
CompletedFirst Posted
Study publicly available on registry
October 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2026
CompletedOctober 6, 2025
October 1, 2025
4 months
February 10, 2025
October 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
aortic VTI variation
measured by apical 5 cavity TTE
At two time points: prior to blood donation (baseline) and at completion of donation (at catheter withdrawal) - at day 0, 15 minutes after baseline
Secondary Outcomes (8)
Shock index variation
At three time points: prior to blood donation (baseline), at completion of donation (at catheter withdrawal) at day 0, 15 minutes after baseline ; and 15 minutes after blood donation (at day 0, 30 minutes after baseline)
E wave variation
At three time points: prior to blood donation (baseline) , at completion of donation (at catheter withdrawal) at day 0, 15 minutes after baseline ; and 15 minutes after blood donation at day 0, 30 minutes after baseline
e' wave variation
At three time points: prior to blood donation (baseline), at completion of donation (at catheter withdrawal) at day 0, 15 minutes after baseline and 15 minutes after blood donation at day 0, 30 minutes after baseline
A wave variation
At three time points: prior to blood donation (baseline), at completion of donation (at catheter withdrawal) at day 0, 15 minutes after baseline and 15 minutes after blood donation at day 0, 30 minutes after baseline
E/A ratio variation
At three time points: prior to blood donation (baseline), at completion of donation (at catheter withdrawal) at day 0, 15 minutes after baseline and 15 minutes after blood donation at day 0, 30 minutes after baseline
- +3 more secondary outcomes
Study Arms (1)
experimental
EXPERIMENTALInterventions
TTE will be performed before, just after and 15 minutes after a blood donation, with measurement of aortic VTI, E wave, e' wave, A wave and left ventricle global longitudinal strain
Eligibility Criteria
You may qualify if:
- Healthy adult volunteers eligible for blood donation according to French Blood Establishment (EFS) standards.
- Age between 18 and 40 years. Participants who have provided written, informed consent. Affiliated with or a beneficiary of a social security system.
You may not qualify if:
- Obesity (BMI \> 30 kg/m²) or underweight (BMI \< 18 kg/m²). Body weight over 96 kg. History of valvular heart disease, ischemic heart disease, or congestive heart failure.
- Known allergy to ultrasound gel. Current medications that could affect hemodynamic response to blood loss (e.g., antihypertensives, antiepileptics, NSAIDs).
- Participation in other human research studies defined as Category 1. Subjects under legal protection, including guardianship or curatorship. Pregnant, lactating, or breastfeeding women. Conditions that contraindicate blood donation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centre Hospitalier Universitaire de Nīmeslead
- GIRCI SOHOcollaborator
- Ministry of Health, Francecollaborator
Study Sites (1)
Centre Hospitalier Universitaire de Nîmes
Nîmes, Occitanie, 30900, France
Related Publications (1)
Lamia B, Ochagavia A, Monnet X, Chemla D, Richard C, Teboul JL. Echocardiographic prediction of volume responsiveness in critically ill patients with spontaneously breathing activity. Intensive Care Med. 2007 Jul;33(7):1125-1132. doi: 10.1007/s00134-007-0646-7. Epub 2007 May 17.
PMID: 17508199BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 10, 2025
First Posted
October 6, 2025
Study Start
October 2, 2025
Primary Completion
February 1, 2026
Study Completion
February 1, 2026
Last Updated
October 6, 2025
Record last verified: 2025-10